1. The Selective NLRP3-inflammasome inhibitor MCC950 Mitigates Post-resuscitation Myocardial Dysfunction and Improves Survival in a Rat Model of Cardiac Arrest and Resuscitation

   • Guanghui Zheng
   • Fenglian He
   • Wanchun Tang

   Original Article Open access 01 January 2022 Pages: 423 - 433

   

2. Mechanism of METTL3-Mediated m⁶A Modification in Cardiomyocyte Pyroptosis and Myocardial Ischemia–Reperfusion Injury

   • Xiang Wang
   • Yi Li
   • Fang Wang

   Original Article 23 January 2022 Pages: 435 - 448

   

3. Flavopiridol Mitigates the Progression of Monocrotaline-Induced Pulmonary Hypertension in Rats by Targeting Cyclin-Dependent Kinase 9

   • Qi Jia
   • Zhiqiang Hu
   • Weike Mao

   Original Article Open access 28 January 2022 Pages: 449 - 460

   

4. Empagliflozin Ameliorates Ouabain-Induced Na⁺ and Ca²⁺ Dysregulations in Ventricular Myocytes in an Na⁺-Dependent Manner

   • Xiaodong Peng
   • Linling Li
   • Nian Liu

   Original Article 04 January 2022 Pages: 461 - 469

   

5. Silencing METTL3 Stabilizes Atherosclerotic Plaques by Regulating the Phenotypic Transformation of Vascular Smooth Muscle Cells via the miR-375-3p/PDK1 Axis

   • Jingquan Chen
   • Kun Lai
   • Jianghua Zheng

   Original Article 15 June 2022 Pages: 471 - 486

   

6. Impact of Pancreatic β-Cell Function on Clopidogrel Responsiveness and Outcomes in Chinese Nondiabetic Patients Undergoing Elective Percutaneous Coronary Intervention

   • Xiliang Zhao
   • Jin Wang
   • Yong Zeng

   Original Article 08 November 2021 Pages: 487 - 496

7. Early Trimetazidine Therapy in Patients Undergoing Primary Percutaneous Coronary Intervention for ST Segment Elevation Myocardial Infarction Reduces Myocardial Infarction Size

   • Geng Qian
   • Xin A
   • Yundai Chen

   Original Article 12 November 2021 Pages: 497 - 506

   

8. Candidate Gene of NOS3, MMP3, AGT, and AGT1R and Pathway Analyses for Platelet Reactivity and Clinical Outcomes of Repeat Revascularization After First PCI in Chinese Patients

   • Shuang Zhou
   • Zhe Wang
   • Yimin Cui

   Original Article 03 December 2021 Pages: 507 - 518

9. A Multisite Retrospective Review of Direct Oral Anticoagulants Compared to Warfarin in Adult Fontan Patients

   • Amir Kazerouninia
   • Justin Georgekutty
   • Wilson W. Lam

   Original Article 13 January 2022 Pages: 519 - 527

   

10. Clinical Characteristics and Outcome of Immediate-Release Versus SLOW-Release Carvedilol in Heart Failure Patient (SLOW-HF): a Prospective Randomized, Open-Label, Multicenter Study

    • Chan Soon Park
    • Jin Joo Park
    • Dong-Ju Choi

    Original Article 23 January 2022 Pages: 529 - 537

    

11. The effect of statin adherence on patients with type 2 diabetes after percutaneous coronary intervention for acute coronary syndrome

    • Lina Zhang
    • Weihao Wang
    • Lixin Guo

    Original Article 09 February 2022 Pages: 539 - 547

    

12. Sacubitril/Valsartan Can Reduce Atrial Fibrillation Recurrence After Catheter Ablation in Patients with Persistent Atrial Fibrillation

    • Qiqi Wang
    • Chengui Zhuo
    • Liangrong Zheng

    Original Article 09 February 2022 Pages: 549 - 560

    

13. Comparison of Sodium-Glucose Cotransporter-2 Inhibitor and Dipeptidyl Peptidase-4 Inhibitor on the Risks of New-Onset Atrial Fibrillation, Stroke and Mortality in Diabetic Patients: A Propensity Score-Matched Study in Hong Kong

    • Sharen Lee
    • Jiandong Zhou
    • Qingpeng Zhang

    Original Article Open access 10 February 2022 Pages: 561 - 569

    

14. NF-κB, A Potential Therapeutic Target in Cardiovascular Diseases

    • Weijia Cheng
    • Can Cui
    • Xianwei Wang

    Invited Review Article 07 July 2022 Pages: 571 - 584

    

15. Cholesterol Lowering Biotechnological Strategies: From Monoclonal Antibodies to Antisense Therapies. A Pre-Clinical Perspective Review

    • S. Bellosta
    • C. Rossi
    • A. Baragetti

    Invited Review Article 13 January 2022 Pages: 585 - 598

    

16. When Is It Appropriate to Publish a Meta-Analysis in Cardiovascular Drugs and Therapy?

    • Charles Maynard
    • Salim Virani
    • Yochai Birnbaum

    Editorial 27 February 2023 Pages: 599 - 601

17. Great Drugs, If You Could Just Get Patients to Take Them

    • Reed Otten
    • James C. Blankenship

    Invited Editorial 28 March 2023 Pages: 603 - 604

18. Model-Based Risk Prediction of Rivaroxaban with Amiodarone for Moderate Renal Impaired Elderly Population

    • Ziteng Wang
    • Eleanor Jing Yi Cheong
    • Eric Chun Yong Chan

    Short Communication 27 October 2021 Pages: 605 - 609

    

19. METTL3: a Potential New Target in the Treatment Strategy of Atherosclerosis?

    • Danjun Chen
    • Fang Nie
    • Hongmei Yue

    Letter to the Editor 05 December 2022 Pages: 611 - 612